The economic burden of asthma: Direct and indirect costs in Switzerland

European Respiratory Journal

Volumn 13, Issue 2, 1999, Pages 281-286

  Szucs, T D ^a   Anderhub, H ^b   Rutishauser, M ^c,d  

^a UNIVERSITY OF MILAN   (Italy)

^b University of Basel ^*  (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Asthma; Cost of illness; Costs; Economic evaluation

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; COST OF ILLNESS; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE COST; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SWITZERLAND;

ADULT; ASTHMA; CHILD; COST OF ILLNESS; COSTS AND COST ANALYSIS; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH RESOURCES; HUMANS; MIDDLE AGED; SWITZERLAND;

EID: 0033018957     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13b10.x     Document Type: Article

References (22)

1. Sly RM. Mortality from asthma, 1979-1984. J Allergy Clin Immunol 1988; 82: 705-717.
2. Gergen PJ, Weiss KB. Changing patterns of asthma hospitalisation among children: 1979 to 1987. JAMA 1990; 264: 1688-1692.
3. Mortality statistics. Bern, Swiss Federal Office for Statistics, 1997.
4. Elixhauser A, ed. Healthcare cost-benefit and cost-effectiveness analysis (CBA/CEA). From 1979 to 1990: a bibliography. Med Care 1993; 3: Suppl. 1-149.
5. Szucs TD, Schramm W. Die soziookonomische Evaluation. Einführung in die Methodologie. Hämostasealogie 1994; 14: 84-89.
6. Drummond MF, Stoddard GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford, Oxford Medical Publications, 1987.
7. Hodgson TA. Costs of illness in cost-effectiveness analysis: a review of the methodology. Pharmaco Economics 1994; 5: 536-552.
8. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financ Rev 1985; 7: 61-80.
9. Arzneimittelkompendium der Schweiz. Basel. Documed, 1997.
10. Swiss Statistical Yearbook. Zürich, Neue Zürcher Zeitung, 1997.
11. Leuenberger P. Air pollution in Switzerland and respiratory disease in adults. Results of the cross-sectional part of the Salpadia study. [German]. Schweiz Rundsch Med Prax 1995; 84: 1096-1100.
12. Robertson CF, Bishop J, Sennhauser FH, Mallol J. International comparison of asthma prevalence in children: Australia, Switzerland, Chile. Pediatr Pulmonol 1993; 16: 219-225.
13. Mellis CM, Peat JK, Bauman AE, Woolcock AJ. The cost of asthma in New South Wales. Med J Aust 1991; 155: 522-528.
14. National Asthma Campaign. Report on the cost of asthma in Australia, 1992, 14-33.
15. Teeling-Smith G. Asthma. London, Office of Health Economics, 1990.
16. Thompson S. On the social costs of asthma. Eur J Respir Dis 1984; 65: 185-191.
17. Jacobson L, Lindgren B. Astma. De samhällsekonomiska kostnaderna. Studier i hälsöckonomia 8. Lurid, Lund Universitet, 1995.
18. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326: 862-866.
19. Nowak D, Volmer T, Wettengel R. Asthma bronchiale -eine Krankheitskostenanalyse. Pneumologie 1996; 50: 364-371.
20. Graf von der Schulenburg JM, Greiner W, Molitor S, Kielhorn A. Cost of asthma therapy in relation to severity. [Kosten der Asthmatherapie nach Schweregrad. Eine cempirische Untersuchung]. Med Klin 1996; 91: 670-676.
21. International Medical Statistics. Verschreibungsindex Pharma Switzerland, 1998.
22. Spitalstatistik [Swiss hospital statistics], H+, Aarau, 1997.